AstraZeneca FD may leave

The respected finance director of AstraZeneca, Jon Symonds, may decide to
leave the FTSE100 drug-maker after he was edged out by David Brennan in the race
to replace AstraZeneca’s CEO Sir Tom McKillop.

Symonds, who has steered the company through a difficult period when its
shares plummeted due to problems with its drug development pipeline, said he
would ‘work it through’ with Brennan before making a decision about his future
at the group.

‘The best man won – that’s who the board picked,’ Symonds told The

If Symonds does leave AstraZeneca, the 100 Group, an association of FTSE100,
will be forced to recruit a new head, as Symonds currently chairs the
influential group.

Related reading